
Measurable disease per FET-PET vs MRI in GBM
Neuro-Oncology: The Podcast
Published: Sat Feb 08 2025
Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments",...
No transcript available.